#flugen

[escapingfools]

Fear n' Dare. Base on a sticker of my friend @wart89 #skateordie #brokenbones #flugen #wings #speedofsound #kunst #goingsweet #wannado #losethetime #tattoo #gpdgaf (hier: Flensburg)

[butareyouhappymorgs-blog]

Es imposible volar cuando tienes los bolsillos llenos de miedo. Porque pesa. Pesa mucho.

unknown

[ao3feed-tododeku]

Denki Kaminari's Strange Secrets?!?

Denki Kaminari's Strange Secrets?!? by Arkticc weeb

"Mein Sohn! Wir mussen auf Japan Flugen!" Denki's father shouts at his son from the foyer of the Kaminari's home. "Ich komme, Vater! Meine Tasche ist fertig!" The black haired boy with the yellow highlights shouted, grabbing a grey Jansport backpack by his bedroom door and rushing downstairs. The family of four hurried outside and into the tanned and brown van, rushing to the airport to evacuate the surprise attack the hero's targeted on the family.

Words: 1110, Chapters: 1/1, Language: English

Fandoms: 僕のヒーローアカデミア | Boku no Hero Academia | My Hero Academia

Rating: General Audiences

Warnings: Creator Chose Not To Use Archive Warnings

Categories: Gen, M/M

Characters: Kaminari Denki, Class 1-A, Bakusquad, Kirishima Eijirou, Bakugou Katsuki, Sero Hanta, Shinsou Hitoshi, Ashido Mina

Relationships: Kaminari Denki/Shinsou Hitoshi, Midoriya Izuku/Todoroki Shouto, Aizawa Shouta | Eraserhead/Yamada Hizashi | Present Mic, Bakugou Katsuki/Kirishima Eijirou, Ashido Mina & Bakugou Katsuki & Kaminari Denki & Kirishima Eijirou & Sero Hanta

Additional Tags: bnha, mha, boku no hero academia, My Hero Academia, Anime, First Fanfic lmao, i don't like putting tags, they're very tedious

Read Here: https://archiveofourown.org/works/35303197

[ao3feed-hitoshi-shinsou]

Denki Kaminari's Strange Secrets?!?

Denki Kaminari's Strange Secrets?!? by Arkticc weeb

"Mein Sohn! Wir mussen auf Japan Flugen!" Denki's father shouts at his son from the foyer of the Kaminari's home. "Ich komme, Vater! Meine Tasche ist fertig!" The black haired boy with the yellow highlights shouted, grabbing a grey Jansport backpack by his bedroom door and rushing downstairs. The family of four hurried outside and into the tanned and brown van, rushing to the airport to evacuate the surprise attack the hero's targeted on the family.

Words: 1110, Chapters: 1/1, Language: English

Fandoms: 僕のヒーローアカデミア | Boku no Hero Academia | My Hero Academia

Rating: General Audiences

Warnings: Creator Chose Not To Use Archive Warnings

Categories: Gen, M/M

Characters: Kaminari Denki, Class 1-A, Bakusquad, Kirishima Eijirou, Bakugou Katsuki, Sero Hanta, Shinsou Hitoshi, Ashido Mina

Relationships: Kaminari Denki/Shinsou Hitoshi, Midoriya Izuku/Todoroki Shouto, Aizawa Shouta | Eraserhead/Yamada Hizashi | Present Mic, Bakugou Katsuki/Kirishima Eijirou, Ashido Mina & Bakugou Katsuki & Kaminari Denki & Kirishima Eijirou & Sero Hanta

Additional Tags: bnha, mha, boku no hero academia, My Hero Academia, Anime, First Fanfic lmao, i don't like putting tags, they're very tedious

Read Here: https://archiveofourown.org/works/35303197

[goblin-writer]

Blitzgeschichten 003: In Deiner Schuld

Ich hab schon lange nicht mehr auf Deutsch geschrieben un wollte unbedingt mitmachen. Es gibt hier warscheinlich noch mehrere Fehler aber ich wollte so schnell wie moeglich etwas hierfuer schreiben. Also Danke an @blitzgeschichten​ fuer nen Tollen Prompt.

I will translate and post this in English soon(tm) too. Keep an eye out if you are interested.

Der rothaarige mann stand zum sechsten mal in einer Woche im Eingangsbereich. Die maskierte Person blickte zu ihm runter und seufzte. Warum habe ich mich da reingemischt. In der Kneipe „Zum Hain“ ging es immer rauflustig zu, die verdunkelten Laternen und die schwarz lackierten Tische gab den Besuchern ein gefühl von Anonymität.

„Du schuldest mir nichts. Du siehst ja ich stehe und laufe als ob nichts passiert ist.“ Dass war nicht ganz ehrlich. Die maskierte Person versuchte den Schmerz nicht zu zeigen, die Wunde musste noch stramm gebunden bleiben, ansonsten würde das Blut wieder in den Verband laufen.

An dem Abend war es wirklich draufgegangen. Zwei Söldner Kompanien sind ins prügeln geraten. Das war eigentlich normale Sache in der Kneipe, die maskierte Figur hatte sich schon zurückgesetzt und wollte einfach dem Lärm des Laboratoriums entkommen. Aber da musste einer der Narren einen Degen ziehen und den ganzen Abend verderben.

Die Figur hatte sich genervt zwischen ein Paar Söldnern und dem rothaarigen mann gestellt. Wenn Soeldner sich schon abstechen wollen, sollten sie auch nur untereinander beschäftigen. Aber so wie immer musste gekämpft werden, es war schon fast Ritual das sich die Figur beschäftigen musste um Unschuldige zu beschützen. Dieses mal hatte Sie nicht damit gerechnet dass ein Söldner den Degen würfen würde.

Als der Degen sich in die Seite der Figur senkte, trieb Sie die zwei Söldner zurück. Der mann und seine Kumpanen hatten ihr gedankt und wollten Sie weiterfeiern einladen. Nach so einer Auseinandersetzung musste die Figur möglichst schnell zum Medicus und hat versucht aus der Kneipe zu schwanken. Doch vordem Sie den halben Weg zur Tür geschwankt ist, hat der Schankraum sich brutal gepurzelt und die Welt ist kürzlich im Dunkeln verschwunden.

Den nächsten Morgen hat die Figur sich stöhnend auf den Ellenbogen gestützt. Ein Brief lag auf dem Nachttisch. 

„Ich wollte dir für euren Heldentum Gestern in der Kneipe Danken. Wir alle stehen in eurer Schuld. Hoffentlich kann ich Ihnen Persönlich Danken in dem ich vielleicht in Ihrem Laboratorium als Assistent meine Schuld zurückzahlen kann.“Es waren schon sechs Tage, und dieses Ritual ging der Figur langsam auf die Nerven. Dennoch könnte Sie ein wenig Hilfe gebrauchen. Ob der rothaarige mann hilfreich seien würde musste wahrscheinlich ermittelt werden wenn es wieder Frieden geben sollte.

„Vielleicht koennte ich einen Assistenten gebrauchen. Eine Woche wird genug sein um deine Schuld zurückzuzahlen.“

So wurde Sie vielleicht ein wenig mehr Frieden haben, und wenn er doch letztendlich für etwas gut war wurde es überraschend und vielleicht ein wenig erfrischend sein. Schon flugen ehrgeizige Pläne in Ihre Gedanken. Unter der Maske lächelte die Figur, eine Versuchsperson erlaubte mehr Experimente, die Woche würde vielleicht doch noch arbeitsreich sein.

[phil-forum-blog]

Reisewarnung! Das Auswärtige Amt rät von Flügen auf die Philippinen ab

Reisewarnung! Das Auswärtige Amt rät von Flügen auf die Philippinen ab

Terroristen machen auch vor Urlaubsparadiesen nicht Halt. Eine islamistische Gruppierung auf den Philippinen überfiel ein deutsches Paar, tötete die Frau sofort und enthauptete nach dreimonatiger Geiselhaft nun auch den Mann. Jetzt reagiert das Auswärtige Amt. Ab sofort gibt es für Teile der Philippinen eine Reisewarnung des Auswärtigen Amts. Sie gilt für Zentral- und Westmindanao, die…

[musicarenagh]

Almwaya Shares Their Masterpiece Album 'Riding A Camel In The Middle Of The Sea'

Almwaya Shares Their Masterpiece Album ‘Riding A Camel In The Middle Of The Sea’

Maya Aghniadis and Wael Sami Elkholhy formed the band Almwaya to create music. The multi-talented Maya Aghniadis is from Lebanon. Throughout Lebanon and Europe as Flugen, she performed downtempo electronic rhythms with poetic melodies and released numerous CDs. Growing up in Cairo, Egyptian musician and actor Wael Sami Elkholy quickly became one of the region’s most well-known performers. His two…

[thisuserismadd]

https://play.anghami.com/song/93804906?adj_t=dgl0aa8_64v1dnl&adj_campaign=ios&adj_adgroup=song&adj_creative=108035361

[ao3feed-bakusquad]

Denki Kaminari's Strange Secrets?!?

Denki Kaminari's Strange Secrets?!? by Arkticc weeb

"Mein Sohn! Wir mussen auf Japan Flugen!" Denki's father shouts at his son from the foyer of the Kaminari's home. "Ich komme, Vater! Meine Tasche ist fertig!" The black haired boy with the yellow highlights shouted, grabbing a grey Jansport backpack by his bedroom door and rushing downstairs. The family of four hurried outside and into the tanned and brown van, rushing to the airport to evacuate the surprise attack the hero's targeted on the family.

Words: 1111, Chapters: 1/1, Language: English

Fandoms: 僕のヒーローアカデミア | Boku no Hero Academia | My Hero Academia

Rating: General Audiences

Warnings: Creator Chose Not To Use Archive Warnings

Categories: Gen, M/M

Characters: Kaminari Denki, Class 1-A, Bakusquad, Kirishima Eijirou, Bakugou Katsuki, Sero Hanta, Shinsou Hitoshi, Ashido Mina

Relationships: Kaminari Denki/Shinsou Hitoshi, Midoriya Izuku/Todoroki Shouto, Aizawa Shouta | Eraserhead/Yamada Hizashi | Present Mic, Bakugou Katsuki/Kirishima Eijirou, Ashido Mina & Bakugou Katsuki & Kaminari Denki & Kirishima Eijirou & Sero Hanta

Additional Tags: bnha, mha, boku no hero academia, My Hero Academia, Anime, First Fanfic lmao, i don't like putting tags, they're very tedious

Read Here: https://archiveofourown.org/works/35303197

[myabhijitr]

Influenza Vaccines Market to surpass USD 6.0 Billion with Growing at a CAGR of 4.4% by Forecast 2025 | GlaxoSmithKline, Sanofi, MedImmmune LLC

As part of major organic initiatives by market participants, a rising pipeline product will be developed into a new vaccine product. For example, in 2017, the MHRA approved Seqirus’ FLAUD, the first and only adjuvant-based trivalent influenza vaccine, against influenza virus in the elderly (adults aged 65 and above). In the same year, Seqirus launched its influenza vaccine portfolio in the United States, with over 50 million doses for protection against seasonal influenza in 2017-2018.

A comprehensive study on the impact of the Covid-19 pandemic on the global Influenza Vaccines Market is also crafted in the report. Impact analysis covers a wide range of factors including supply chain analysis, market expansion, major restraining factors, and future growth during the pandemic. This will enable the investor/user to better understand the overall picture of the market and make decisions that will be favorable to streamline the business.

Get Sample Report with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/1705

The portfolio includes FLAUD, FLUCELVAX QUADRIVALENT, AFLURIA QUADRIVALENT, AFLURIA, and FLUVIRIN. Moreover, in 2017, FluGen, Inc., received US$ 14.4 million by Department of Defense for evaluating Universal Flu Vaccine, RedeeFlu, of Mismatched Strains. In Sep 2017, Novavax initiating phase1/2 clinical trials for nanoparticle seasonal influenza vaccine in older adults. In April 2018, BiodVax Pharmaceuticals LTD., started enrollment of patients for phase 2 clinical trials for universal flu vaccine candidate, M-001.

The rising incidence of seasonal influenza in the paediatric population is driving demand for novel vaccinations. Influenza is thought to affect between 5% and 10% of adults, as well as 20 to 30% of children. Furthermore, firms are working to close the gap between demand and supply by developing vaccines using cutting-edge technologies such as egg-based, cell-based, and recombinant-based products. . Furthermore, market growth is aided by increased awareness and measures to boost vaccine coverage. The Advisory Committee on Immunization Practices (ACIP) recommends routine annual influenza vaccination for everyone over the age of six months in its 2017–2018 recommendations guidelines. However, the high cost of vaccine development is projected to stifle market expansion in the future.

Key takeaways of the Influenza Vaccines Market:

The global influenza vaccines market is expected to expand at a CAGR of 4.4% during the forecast period (2018 – 2026), owing to increasing R&D activities of market players.

Trivalent vaccine is expected to dominate vaccine type segment, owing to more number of products

Influenza type A virus segment is expected to be predominant, owing to increasing prevalence of type A based infection

Pediatric being more susceptible to influenza virus is expected to lead age group segment

Some of the major players involved in global influenza vaccines market include Seqirus Vaccines Limited, GlaxoSmithKline plc

Want to “ahead” with your competiors request a PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1705

[astronautalis]

Die beste zeug, nach Zügen, Flugen, und Automobilen, ist eine bekanntes Gesicht (at Michelberger Hotel)

[pavanghage]

Infant Resuscitation System Market 2021-Global Industry Analysis, By Key Players, Segmentation, Application, Demand And Forecast By 2027

"

Influenza A Virus, H3N2 Subtype Infections Drug Market is analyzed with industry experts in mind to maximize return on investment by providing clear information needed for informed business decisions. This research will help both established and new entrants to identify and analyze market needs, market size and competition. It explains the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities and the threats faced by key players.

Sample Copy of This Report:https://axelreports.com/request-sample/53773

A 360 degree outline of the competitive scenario of the Global Influenza A Virus, H3N2 Subtype Infections Drug Market is presented by Axel Reports Market Insights. It has a massive data allied to the recent product and technological developments in the markets.

It has a wide-ranging analysis of the impact of these advancements on the market’s future growth, wide-ranging analysis of these extensions on the market’s future growth. The research report studies the market in a detailed manner by explaining the key facets of the market that are foreseeable to have a countable stimulus on its developing extrapolations over the forecast period.

Reasons for buying this report:

It offers an analysis of changing competitive scenario.

For making informed decisions in the businesses, it offers analytical data with strategic planning methodologies.

It offers seven-year assessment of Global Influenza A Virus, H3N2 Subtype Infections Drug

It helps in understanding the major key product segments.

Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.

It offers regional analysis of Global Influenza A Virus, H3N2 Subtype Infections Drug Market along with business profiles of several stakeholders.

It offers massive data about trending factors that will influence the progress of the Global Influenza A Virus, H3N2 Subtype Infections Drug

Get ToC for the overview of the premium report @ https://axelreports.com/industry-analysis/2021-2027-global-and-regional-influenza-/53773

By Market Players: AbbVie Inc Inovio Pharmaceuticals, Inc. Celltrion, Inc. AIMM Therapeutics B.V. ILiAD Biotechnologies, LLC Aphios Corporation Medicago Inc. Glide Pharmaceutical Technologies Limited FluGen, Inc. Johnson & Johnson Sarepta Therapeutics, Inc. Zydus Cadila Healthcare Limited MedImmune, LLC VBI Vaccines Inc. OPKO Health, Inc. Mucosis B.V. Visterra, Inc. NanoViricides, Inc. By Type NEO-8877 NP-025 NSC-61610 NVINF-1 Others By Application Clinic Hospital Others

A detailed outline of the Global Influenza A Virus, H3N2 Subtype Infections Drug Market includes a comprehensive analysis of different verticals of businesses. North America, Latin America, Asia-Pacific, Africa, and Europe have been considered for the studies on the basis of several terminologies.

This is anticipated to drive the Global Influenza A Virus, H3N2 Subtype Infections Drug Market over the forecast period. This research report covers the market landscape and its progress prospects in the near future. After studying key companies, the report focuses on the new entrants contributing to the growth of the market. Most companies in the Global Influenza A Virus, H3N2 Subtype Infections Drug Market are currently adopting new technological trends in the market.

Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global Influenza A Virus, H3N2 Subtype Infections Drug Market. The feasibility of the new report is also measured in this research report.

Make an Enquiry for purchasing this Report :https://axelreports.com/enquiry-before-buying/53773

Table of Contents:

Global Influenza A Virus, H3N2 Subtype Infections Drug Market Overview

Economic Impact on Industry

Market Competition by Manufacturers

Production, Revenue (Value) by Region

Production, Revenue (Value), Price Trend by Type

Market Analysis by Application

Cost Analysis

Industrial Chain, Sourcing Strategy and Downstream Buyers

Marketing Strategy Analysis, Distributors/Traders

Market Effect Factors Analysis

Global Influenza A Virus, H3N2 Subtype Infections Drug Market Forecast

ABOUT US:

Axel Reports has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact: Axel Reports Akansha G (Knowledge Partner) Office No- B 201 Pune, Maharashtra 411060 Phone: US +18488639402 Email: sales@axelreports.com/ Web: https://axelreports.com/

"

[futureresearchreportstrends]

Influenza is a contagious respiratory infection that causes cough, runny nose, severe illness. As per the World Health Organization, 2018, over 4 million people were diagnosed with severe illness whereas over 0.1 million influenza-related deaths were registered. Additionally, as per the report published by Center for Disease Control and Prevention in 2019, over 90 pediatric deaths were registered owing to flu. Furthermore, growing research and development activities along with current clinical trials for developing novel flu vaccines shall bolster the flu vaccines market growth. Moreover, rise in the number of healthcare centers in both developed and developing nations has boosted the proliferation of the market. Additionally, many key players are heavily investing in research and development activities for increasing their manufacturing capabilities and the product spectrum. These vendors are establishing new facilities for enhancing their production capabilities. The demand for flu vaccines has skyrocketed due to the current COVID-19 pandemic and many companies are initiating in producing vaccines for this virus. For example, Bharat Biotech has declared to collaborate with FluGen, a US-based biotech company and the University of Wisconsin Madison for experimenting with flu vaccines that have the potential of fighting off the SARS COV-2 virus. Many players have also reached the levels of advance clinical trials and government bodies are providing financial as well as infrastructural support to these companies.

[freesuitwhispers]

Global   Influenza Vaccines Market Segmentation, Demand and Supply 2020-2026

Summary – A new market study, “United States Influenza Vaccines Market Forecast 2020 - 2027”has been featured on WiseGuyReports.

The United States influenza vaccines market is set to surpass USD 5.1 Billion by 2027.

Also Read: https://www.newyorktelegraph.com/news/266198057/united-states-influenza-vaccines-market-2020---industry-analysis-size-share-strategies-and-forecast-to-2027

Key Highlights:

 • Influenza vaccines demand is anticipated to increase in the US for 2020 – 2021 Flu Season

• Emergent BioSolutions Signs Contract with Novavax to Manufacture NanoFlu

• Dynavax and Mount Sinai Announce Collaboration to Progress a Universal Influenza Vaccine

• AstraZeneca Ships Flumist Quadrivalent Vaccine in the US for 2020-2021 Flu Season

• Other three companies (Sanofi, GSK and Seqirus) have also Commences Shipping Flu Vaccines in the US for 2020-2021 Flu Season

 Report Scope:

 • The Market Size of the United States Influenza Vaccines Market with Seven Years Forecast

• Analyses the United States Overall Persons Being Vaccinated with Influenza Vaccines with Seven Years Forecast

• Examines the United States Children Being Vaccinated with Influenza Vaccines with Seven Years Forecast

• Scrutinizes the United States Adults Being Vaccinated with Influenza Vaccines with Seven Years Forecast

• Delivers Inclusive Insights on the Latest Pricing Trends and Analysis

• Covers a Complete Analysis of the US Influenza Vaccines Production, Supply, and Allocation (By Companies)

• Delivers a Comprehensive Outline of the US Influenza Vaccines Distribution and Demand

• Studies the Latest Effectiveness of the Influenza Vaccines in the United States

• Thoroughly Assessment of the Rapid Diagnostic Testing for the Management of Influenza

• Meticulously Assesses of the Distribution Channel and Technique of the Influenza Vaccination in the United States

• Detailed Insights into the Regulatory Framework of the United States Influenza Vaccines Market

• Features Reimbursement Patterns of the United States Influenza Vaccines Market

• Tracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions. Collaboration, Distribution, Exclusive and Licensing Agreement

• An Insightful Investigation has been done on Promising Influenza Vaccines in the Clinical Development

• Analyses the Most Recent Clinical Trials of the Influenza Vaccines between 2019 and 2020

• Delivers an In-Depth Analysis of Evolving Market Trends, Drivers and Restraints of the United States Influenza Vaccines Market

• A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Influenza Vaccines Market Value, and Recent Development

• An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development

 “United States Influenza Vaccines Market Forecast 2020 - 2027” is based on an inclusive study of the entire United States influenza vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States influenza vaccines market. The study also presents a comprehensive analysis of the market dynamics and estimation of the market size over the forecast period 2020 – 2027.

 The report comprehends a profound study with size in terms of both value and volume of the US influenza vaccines market. The report delivers a clear understanding of the up-to-date and future growths of the United States influenza vaccines market. The report also discovers a comprehensive investigation of the children and adults vaccinated with influenza vaccines in the United States from 2013 to 2019 and forecasts to 2027. The report also details the latest information about influenza vaccine production, supply, and allocation by major companies in the United States between 2014 – 2015 and 2020 - 2021.

 An all-inclusive examination has been done on the pricing, distribution, demand, and effectiveness of the influenza vaccines in the United States. It also provides a deep and in-depth evaluation of the distribution channel and technique of the influenza vaccination in the United States.

 Additionally, this up-to-date report describes the latest features reimbursement pattern and offers a clear view of the regulatory framework of the United States influenza vaccines market. Moreover, the report analyses the most recent clinical trials review promising influenza vaccines in clinical development and rapid diagnostic testing for the management of influenza. The report also tracks and analyses competitive developments, including collaboration, merger & acquisition, distribution, exclusive and licensing agreement, new vaccine developments, and R&D activities in the market. The report also delivers an in-depth analysis of evolving market trends, drivers, and restraining forces that influence the growth of the market.

 The report also analyses detailed profiles of innovative and leading players with information on business overview, companies’ vaccines portfolio, influenza vaccines market value, and the latest developments.

 Other emerging players are making novel technology-based vaccines that are likely to affect the market share during the forecast period. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with phase, platform technology, and the latest development.

 The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

 • Sanofi Pasteur

• GlaxoSmithKline (GSK)

• Seqirus (CSL Limited)

• AstraZeneca

• Novavax

• BiondVax Pharmaceuticals Ltd.

• Medicago

• Moderna Inc

• Pneumagen

• Daiichi–Sankyo

• Altimmune

• FluGen

• Imutex

 Key Questions Addressed by the Report

 • What is the current size of the overall influenza vaccines market in the United States?

• How much will this market be worth from 2020 to 2027?

• How many persons being vaccinated with influenza vaccines in the US during 2013 – 2027?

• How effective is influenza (flu) shot for 2020?

• What percentage of the United States do people get the flu vaccine?

• What are the key marketed influenza vaccines available in the United States?

• What are the major drivers of the United States influenza vaccines market?

• What are the major inhibitors of the United States influenza vaccines market?

• What is the reimbursement pattern in the United States influenza vaccines market?

• What is the regulatory framework in the United States influenza vaccines market?

• What are the major deals and agreement happenings in the United States influenza vaccines market?

• What are the upcoming influenza vaccines that will have a significant impact on the market in the future?

• Who are the top market players? What are their happenings, vaccines revenue, current developments, and scenarios?

• Who are the emerging players? What are their happenings, clinical development, platform technology, phase, and current developments?

• How is the market predicted to develop in the future?

FOR MORE DETAILS : https://www.wiseguyreports.com/reports/5752207-united-states-influenza-vaccines-market-forecast-2020-2027

About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.                

 Contact Us:

NORAH TRENT                                                      

sales@wiseguyreports.com       

Ph: +162-825-80070 (US)                          

Ph: +44 2035002763 (UK)  

[vivanls]

New Post has been published on Vivan Life Sciences

New Post has been published on https://www.blog.vivanls.com/all-eyes-are-on-india-that-makes-60-of-the-worlds-vaccines/

All eyes are on India that makes 60% of the world’s vaccines !

As international vaccine companies and academic institutions race the clock to deliver a safe Covid-19 vaccine, all eyes are on India that makes 60% of the world’s vaccines. And within India, if there is one destination that all of them are making a beeline for it is Hyderabad. The city has the capacity to churn out well over a third of the global vaccine supply. Be it India’s first indigenous Covid-19 vaccine candidate Covaxin or Russia’s Sputnik V, Johnson & Johnson’s Ad26.Cov2.S, FluGen’s CoroFlu or even Sanofi’s under development vaccine candidates, all have a Hyderabad connect. Whether a successful Covid-19 vaccine is developed in Hyderabad or not, a vaccine developed anywhere in the world will be churned out of Hyderabad, feels Dr Varaprasad Reddy, founder & chairman, Shantha Biotechnics Ltd. “All Hyderabad vaccine companies are robust in manufacturing technology and have the capacity to manufacture millions of doses with good standards,” says Reddy, who is awaiting Sanofi’s own vaccine candidate in the first half of 2021, a chunk of which is expected to be manufactured in Hyderabad. Sanofi had acquired Shantha Biotechnics in 2009. Hyderabad will be an integral part of the Covid-19 solution just by the dint of the sheer vaccine manufacturing capacity it houses, feels Mahima Datla, managing director, Biological E Limited, which has a tie-up with Baylor College of Medicine, Texas, to develop its own vaccine candidate and a tech collaboration to manufacture Johnson & Johnson’s vaccine here. In fact, most of Hyderabad’s vaccine manufacturers are in informal discussions for a manufacturing collaboration so that whenever a successful candidate is developed they can offer their manufacturing capabilities. The Telangana government too is gung-ho about Hyderabad’s role in the Covid-19 battle given. “Being the vaccine capital of the world, we are fully committed to playing an enabling role in global vaccination efforts against Covid-19 and proactively support our companies to quickly ramp up production to serve the world,” said Jayesh Ranjan, principal secretary, industries & ITE&C, Telangana. Reference: Healthworld.com